TP53 and neoplasm: These tumours probably have mutations in genes other than FGFR3 or TP53, but with a similar effect (activation of the FGFR3 signaling pathway in Ta tumors of low grade and mutations of genes causing genetic instability in high-grade or high-stage tumors).